Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Lee430on Sep 22, 2022 12:44pm
188 Views
Post# 34979396

RE:RE:RE:RE:RE:A nice report on Trogarzo on a Spanish patient

RE:RE:RE:RE:RE:A nice report on Trogarzo on a Spanish patientThere has been so few of us Looongs posting on this board it kinda feels like we are pen pals now.
I appreciate all the good info as it very much helps me to keep the faith....Possibly we can all put a face to our avatar and meet at the peel pub once we are proven to be the "genius and not the chump"


scarlet1967 wrote: I will be happy with a D+ but on a serious note if you recall I made a list of all relevant items related to the company. Sometimes when there are recent news I add those topics to the list. I certainly appreciate all others inputs including yourself, Speco, quertly, Wino, Barkley and many others I just wish this board/this company was followed by far many more investors! 

palinc2000 wrote: Exactly but I was wondering why Scarlett did not pick that up!!!! I have lowerd his grade to 99.9% from 100% 

SPCEO1 wrote: I have an automated internet search set up for Trogarzo on Google and get a report most days on any mentions showing up across the world wide web.

But Scarlett is the one to ask about how to do these searches best!

palinc2000 wrote: There is no doubt that the patient is still able to get Trogarzo and I think THTX has /had a system in place to make sure that patients receiving Trog can get access,
The bigger picture is that if more reports like that surface it will help to increase US sales and possibly re open pricing discussions in Europe 
BTW how did you get that report?

 

 




<< Previous
Bullboard Posts
Next >>